antibody therapy

NEW YORK, N.Y. — September 23, 2026 Lupus Research Alliance (LRA) announced the recipients of its 2026 Translational Bridge...

Amsterdam, the Netherlands – August 27, 2026 argenx announced the successful completion of its acquisition of Forte Biosciences, Inc.,...

VANCOUVER, British Columbia, August 10, 2026 AbCellera Biologics Inc. announced positive topline results from the Phase 2 portion of...

VANCOUVER, British Columbia, July 29, 2026 AbCellera Biologics Inc. announced a strategic collaboration with Vertex Pharmaceuticals to research, develop,...

ZURICH, Switzerland, July 20, 2026 VERAXA Biotech AG (NASDAQ: VRXA) announced that it has received Scientific Advice from Germany’s...

SEATTLE, June 17, 2026 Vedana Therapeutics has officially emerged from stealth with $46 million in Series A financing to...

INGELHEIM, Germany and WALTHAM, Mass., May 12, 2026 Boehringer Ingelheim has entered into a global licensing agreement with Immunitas...

CAMBRIDGE, UK, April 8, 2026 Immutrin Ltd has successfully raised £65 million ($87 million) in an oversubscribed Series A...

Cambridge, Massachusetts, USA / Rotterdam, Netherlands / Shanghai, China | March 22, 2026 Harbour BioMed has announced the online...